These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4737462)

  • 1. [Carbohydrate metabolism in acute cerebrovascular diseases].
    Kotoku T; Tanno K; Kutsuzawa T
    Rinsho Shinkeigaku; 1973 Mar; 13(3):166-73. PubMed ID: 4737462
    [No Abstract]   [Full Text] [Related]  

  • 2. Covert diabetes mellitus in ischemic heart and cerebrovascular disease.
    Gertler MM; Leetma HE; Saluste E; Covalt DA; Rosenberger JL
    Geriatrics; 1972 Mar; 27(3):105-16. PubMed ID: 5011200
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carbohydrate metabolism in thyroid diseases].
    Dieterle P; Bottermann P; Landgraf R; Schwarz K; Scriba PC
    Med Klin; 1969 Mar; 64(11):489-95. PubMed ID: 5767435
    [No Abstract]   [Full Text] [Related]  

  • 4. [Obesity and diabetes. I. Blood sugar, blood insulin and NEFA during glucose tolerance test in obese subjects].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1969; 31(1):40-8. PubMed ID: 5402437
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucose tolerance and insulin sensitivity in obesity].
    Balestreri R; Pompei A
    Arch Maragliano Patol Clin; 1966; 22(4):439-51. PubMed ID: 6014634
    [No Abstract]   [Full Text] [Related]  

  • 6. Serial changes in glucose utilization and insulin and growth hormone secretion in acute cerebrovascular disease.
    Huff TA; Lebovitz HE; Heyman A; Davis L
    Stroke; 1972; 3(5):543-52. PubMed ID: 4652729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in glucose tolerance, plasma immunoreactive insulin and free fatty acids in cerebrovascular diseases (author's transl)].
    Yamamoto T
    Fukuoka Igaku Zasshi; 1974 Jul; 65(7):417-36. PubMed ID: 4474118
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of thyroid gland function on various parameters of glucose tolerance in triamcinolone glucose tolerance test. I. Changes of blood sugar, insulin and free fatty acids in the blood].
    Zamrazil V; Nedvídková J; Felt V; Nĕmec J; Havelka J; Neradilová M
    Vnitr Lek; 1975 Mar; 21(3):249-56. PubMed ID: 1119103
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbohydrate metabolism in renal disease.
    Spitz IM; Rubenstein AH; Bersohn I; Abrahams C; Lowy C
    Q J Med; 1970 Apr; 39(154):201-26. PubMed ID: 5449589
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of some parameters of fat and carbohydrate metabolism in weight loss in obese patients].
    Irsigler K; Waldhäusl W
    Wien Klin Wochenschr; 1969 Jul; 81(29):534-6. PubMed ID: 5801624
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carbohydrate tolerance and insulin response in a case of carcinoids].
    Trisotto A; Frezzato S; Federspil G; Scandellari C
    Minerva Med; 1970 Feb; 61(15):680-3. PubMed ID: 5417558
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on glucose tolerance, serum insulin and free fatty acid in chronic liver disease.
    Parida RK; Santhalia RR; Mishra PK; Pradhan N; Samal KC; Sahoo CS
    J Assoc Physicians India; 1981 Feb; 29(2):119-27. PubMed ID: 7021524
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disorders of carbobohydrate and other types of metabolism in patients with coronary arteriosclerosis].
    Sil'nitskiĭ PA; Avenirova ZA; Orkodashvili LSh
    Sov Med; 1974 Jun; 37(6):18-22. PubMed ID: 4845252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carbohydrate metabolism disorders in stroke].
    Martynov IuS; Shuvakhina NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(9):1281-8. PubMed ID: 494926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbohydrate metabolism in normal pregnancy].
    Herre HD; Kyank H
    Med Klin; 1971 Mar; 65(11):477-83. PubMed ID: 5091001
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carbohydrate and lipid metabolism disorders in early stages of essential hypertension as pathogenetic risk factors of arteriosclerosis].
    Baumann R
    Z Gesamte Inn Med; 1973 Jun; 28(12):Suppl:191-2 c. PubMed ID: 4729276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Active chronic hepatitis and insulin resistance: possible role of glucagon, GH and free fatty acids].
    Bonora E; Coscelli C; Orioli S; Cambi R; Buzzelli G; Gentilini P; Butturini U
    G Clin Med; 1981 Dec; 62(12):831-45. PubMed ID: 7042433
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modifications induced by glucose-1-phosphate on carbohydrate utilization curve after venous loading. Results in normal subjects (preliminary note)].
    Pezzarossa A; Cavazzini G; Coscelli C; Butturini U
    Boll Soc Ital Biol Sper; 1972 Jun; 48(12):318-21. PubMed ID: 5070100
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in carbohydrate metabolism, plasmatic NEFA and immunoreactive insulin in hepatic cirrhosis].
    Gragnoli G; Pupillo A; Montagnani M; Bayeli PF
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1373-90. PubMed ID: 5759915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on serum insulin, blood glucose and nonesterified fatty acid following the oral glucose administration to the normal subjects].
    Yoshimoto A; Okano N; Maezawa A; Ominato K; Sato T; Koseki Y; Komine S
    Radioisotopes; 1982 May; 31(5):245-7. PubMed ID: 6753044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.